ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.665
-1.53%
US Dollar vs AUD
1.51445
0.24%
Bitcoin
60,615.30
-3.86%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Crossject (ALCJ)

  7. Crossject (ALCJ) News

ALCJ

Crossject (ALCJ)

Crossject
Date:
Sort by:
 Showing the most relevant articles for your search:EU:ALCJ
DateTimeSourceHeadlineSymbolCompany
03/05/202401:30GlobeNewswire Inc.Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in EuropeEU:ALCJCrossject
03/05/202401:30GlobeNewswire Inc.Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en EuropeEU:ALCJCrossject
03/05/202401:30GlobeNewswire Inc.Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in EuropeEU:ALCJCrossject
01/05/202403:05GlobeNewswire Inc.Crossject annonce le lancement d’une augmentation de capitalEU:ALCJCrossject
25/04/202415:32GlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
25/04/202415:32GlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
25/04/202415:32GlobeNewswire Inc.Crossject communique ses résultats financiers audités pour 2023EU:ALCJCrossject
11/04/202400:30GlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
03/04/202403:35GlobeNewswire Inc.Crossject trading on Euronext to resume as usual on Wednesday April 3EU:ALCJCrossject
03/04/202403:35GlobeNewswire Inc.La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avrilEU:ALCJCrossject
02/04/202419:30GlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
02/04/202419:30GlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
02/04/202419:30GlobeNewswire Inc.Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023EU:ALCJCrossject
08/03/202417:30GlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
08/03/202417:30GlobeNewswire Inc.Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024EU:ALCJCrossject
08/03/202417:30GlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
27/02/202418:30GlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
27/02/202418:30GlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
27/02/202418:30GlobeNewswire Inc.Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranchesEU:ALCJCrossject
07/02/202403:30GlobeNewswire Inc.Crossject publie une mise à jour stratégique de ses priorités pour 2024EU:ALCJCrossject
07/02/202403:30GlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
07/02/202403:30GlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
02/02/202404:15GlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
02/02/202404:15GlobeNewswire Inc.Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commercialeEU:ALCJCrossject
02/02/202404:15GlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
17/01/202403:15GlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
10/01/202402:21GlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
10/01/202402:21GlobeNewswire Inc.Crossject annonce l’initiation de la couverture de son titre par ODDO BHFEU:ALCJCrossject
10/01/202402:21GlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
05/01/202404:00GlobeNewswire Inc.Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-UnisEU:ALCJCrossject
 Showing the most relevant articles for your search:EU:ALCJ

Your Recent History

ASX
XJO
S&P ASX 200
ASX
RIO
Rio Tinto
NYSE
KO
Coca Cola
ASX
SUN
Suncorp
NYSE
MRK
Merck
ASX
ANZ
Australia And New Zealan...
CCOM
SILVER
SILVER
ASX
AMP
AMP
ASX
FMG
Fortescue
ASX
WDC
Westfield
ASX
NCM
Newcrest Mining
NYSE
VZ
Verizon Communications
ASX
XAO
Australian SE All Ordina...
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
MQG
Macquarie
FX
AUDCAD
AUD vs CAD
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved